Bhopal, November 20: India’s first indigenous H5N1 bird flu vaccine for chickens was dedicated to the nation in Bhopal on Friday, priced at ₹1–2 a dose so that small poultry farmers can afford it. Union Minister for Agriculture and Farmers’ Welfare and Rural Development Shivraj Singh Chouhan also announced a new ₹300 crore laboratory for the city.
The vaccine was developed at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal. According to the Agriculture Ministry, it is the world’s first vaccine against this particular variant of bird flu and is expected to help prevent outbreaks in the poultry sector and cut the losses farmers suffer from animal diseases.
Why the price matters
Mr Chouhan said the vaccine had been priced low so that even small poultry farmers could vaccinate their birds. He said India had recorded more than 500 bird flu outbreaks since the first one in 2006 at Navapur in Maharashtra, where 10 lakh chickens died and lakhs more had to be culled and buried. Around 9 lakh chickens died in 2021 and another 2 lakh this year.
The disease can also pass to mammals and humans, which makes prevention and control especially important, he said.
₹300 crore laboratory
The minister announced a state-of-the-art laboratory in Bhopal at an estimated cost of ₹300 crore. He said there had been a proposal to launch the vaccine from Delhi, but he chose Bhopal so the scientists who developed it could be recognised in the city where they did the work.
The research team comprised Dr S. Nagarajan, Dr Manoj Kumar, Dr C. Tosh, Dr H. V. Murugkar, Dr Aniket Sanyal, Dr Senthil Kumar D., Dr Naveen Kumar and Dr Yogisharadhya R. Mr Chouhan said they had worked through weekends for months under strict biosafety rules, which included sanitisation before and after leaving the laboratory, using 120 litres of water a day for bathing and not keeping pets at home during the research.
Losses from animal diseases
Mr Chouhan said animal husbandry contributes 14 per cent of India’s GDP and poultry another 1 per cent. By the figures he shared, foot and mouth disease causes average annual losses of ₹22,000 crore, lumpy skin disease ₹20,000 crore, brucellosis ₹9,212 crore and peste des petits ruminants, which affects sheep and goats, ₹4,683 crore. Together that comes to about ₹56,000 crore.
Under the National Animal Disease Control Programme, 147 crore 16 lakh free doses of foot and mouth disease vaccine have been given so far, and brucellosis has been brought under control, he said. During the 2022 lumpy skin disease outbreak, 32.8 lakh animals were infected and 1.86 lakh died, after which scientists at Hisar and Izatnagar developed the Lumpi-ProVacInd vaccine.
ICAR-NIHSAD has earlier developed indigenous vaccines for Gumboro disease, Brucella abortus S-19 Delta, classical swine fever and African swine fever.
During his speech, Mr Chouhan also criticised opposition leaders who, he said, questioned India’s constitutional institutions and the abilities of its scientists while speaking abroad.
ICAR Director General Dr M. L. Jat and NIHSAD Director Dr Aniket Sanyal were among those present, along with Madhya Pradesh minister Vishwas Sarang, Bhopal MP Alok Sharma and Bhopal Mayor Malti Rai.
Related: India’s first indigenous H5N1 bird flu vaccine for chickens to be launched on November 20

